Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Anteris Technologies (AMEUF)
OTHER OTC:AMEUF
Holding AMEUF?
Track your performance easily
AMEUF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.20 - $15.80
Previous Close$5.6
Volume10.00
Average Volume (3M)3.39K
Market Cap
$201.10M
Enterprise Value$306.52B
Total Cash (Recent Filing)AU$14.40B
Total Debt (Recent Filing)AU$222.58B
Price to Earnings (P/E)―
Beta2.10
Next Earnings
Feb 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.31
Shares Outstanding15,422,552
10 Day Avg. Volume421
30 Day Avg. Volume3,386
Standard Deviation5.44
R-Squared0.11
Alpha1.17
Financial Highlights & Ratios
Price to Book (P/B)6.74
Price to Sales (P/S)65.07
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-143.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Anteris Technologies News
PremiumCompany Announcements
Anteris Technologies Updates Securities Issuance Plan
PremiumCompany Announcements
Anteris Technologies Redeems Convertible Notes
PremiumCompany Announcements
Anteris Technologies Announces New Director Appointment
PremiumCompany Announcements
Anteris Technologies Advances with SEC Filing
PremiumCompany Announcements
Anteris Technologies Files SEC Statement for Equity Plans
PremiumCompany Announcements
Anteris Technologies Expands with U.S. IPO and Innovations
PremiumCompany Announcements
Anteris Technologies Raises $88.8M in US IPO
PremiumCompany Announcements
Anteris Technologies’ Bold Shift to U.S. MarketsOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
AMEUF FAQ
What was Anteris Technologies’s price range in the past 12 months?
Anteris Technologies lowest stock price was $5.20 and its highest was $15.80 in the past 12 months.
What is Anteris Technologies’s market cap?
Currently, no data Available
When is Anteris Technologies’s upcoming earnings report date?
Anteris Technologies’s upcoming earnings report date is Feb 27, 2025 which is in 67 days.
How were Anteris Technologies’s earnings last quarter?
Anteris Technologies released its earnings results on Aug 22, 2024. The company reported -$1.719 earnings per share for the quarter, missing the consensus estimate of -$0.938 by -$0.782.
Is Anteris Technologies overvalued?
According to Wall Street analysts Anteris Technologies’s price is currently Overvalued.
Does Anteris Technologies pay dividends?
Anteris Technologies does not currently pay dividends.
What is Anteris Technologies’s EPS estimate?
Anteris Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Anteris Technologies have?
Anteris Technologies has 35,939,816 shares outstanding.
What happened to Anteris Technologies’s price movement after its last earnings report?
Anteris Technologies reported an EPS of -$1.719 in its last earnings report, missing expectations of -$0.938. Following the earnings report the stock price went up 0.465%.
Which hedge fund is a major shareholder of Anteris Technologies?
Currently, no hedge funds are holding shares in AMEUF
---
Anteris Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AMEUF Sentiment 87%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-57.31%
12-Months-Change
Fundamentals
Return on Equity
-645.34%
Trailing 12-Months
Asset Growth
-21.58%
Trailing 12-Months
Company Description
Anteris Technologies
Admedus Ltd is an Australia-based healthcare company which develops, commercializes and distributes next-generation medical technologies and devices. It is engaged in the sale and distribution of the infusion medical device and the ADAPT tissue portfolio with a particular focus in the area of cardiovascular Neonatal repair. The business activity of the company is operated through four segment namely Disposable medical product and medical devices distribution; Bio implant operations - inclusive of sales, distribution, and manufacturing; Regenerative medicine R&D-ADAPT technology, and Immunotherapies research and development.
---
Technical Analysis
---